All Pharma News
BeiGene co-founder snag $200M for age-related biotech, with ARCH jumping in

BeiGene co-founder snag $200M for age-related biotech, with ARCH jumping in
Kyle LaHucik ENDPTS
02 Aug 2022
Share Share
Viela Bio Biologic Uplizna (Inebilizumab) Receives Approval in Europe

Viela Bio Biologic Uplizna (Inebilizumab) Receives Approval in Europe
EMA
19 May 2022
Share Share
Compliance officer profited off Horizon-Viela and Jazz-GW deals

Compliance officer profited off Horizon-Viela and Jazz-GW deals
Kevin Dunleavy FIERCEPHARMA
01 Oct 2021
Share Share
Viela Bio Announces Additional Positive Results with UPLIZNA®

Viela Bio Announces Additional Positive Results with UPLIZNA®
BIOSPACE
26 Feb 2021
Share Share
Viela Bio Announces Additional Positive Results with UPLIZNA®

Viela Bio Announces Additional Positive Results with UPLIZNA®
GLOBENEWSWIRE
25 Feb 2021
Share Share
Horizon Therapeutics to Purchase Viela Bio for $3.1 Billion

Horizon Therapeutics to Purchase Viela Bio for $3.1 Billion
John Lauerman BLOOMBERG
03 Feb 2021
Share Share
Viela Bio Announces Data Presentations at the 8th Joint ACTRIMS-ECTRIMS Meeting

Viela Bio Announces Data Presentations at the 8th Joint ACTRIMS-ECTRIMS Meeting
GLOBENEWSWIRE
03 Sep 2020
Share Share
AZ spinoff faces tough task launching its first drug

AZ spinoff faces tough task launching its first drug
Eric Sagonowsky FIERCE PHARMA
15 Jun 2020
Share Share
Viela Bio`s Uplizna (Inebilizumab ) Receives Supplemental Approval in US

Viela Bio`s Uplizna (Inebilizumab ) Receives Supplemental Approval in US
FDA
13 Jun 2020
Share Share
Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon)

Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon)
GLOBENEWSWIRE
11 Jun 2020
Share Share